Angioedema and oral contraception

Dermatology

Volumn 206, Issue 2, 2003, Pages 106-109

  Bouillet, L ^a,b   Ponard, D ^b   Drouet, C ^b   Jullien, D ^c   Massot, C ^a  

^a Service de medecine interne   (France)

^b GRENOBLE UNIVERSITY HOSPITAL   (France)

^c EDOUARD HERRIOT HOSPITAL   (France)

Author keywords

Angioedema; C1Inh; Oral contraception

Indexed keywords

ANTIGEN; COMPLEMENT COMPONENT C1S INHIBITOR; ORAL CONTRACEPTIVE AGENT;

ABDOMINAL DISEASE; ADULT; ANGIONEUROTIC EDEMA; ANTIGEN DETECTION; ARTICLE; BIOLOGICAL TRAIT; CLINICAL ARTICLE; CLINICAL STUDY; DRUG WITHDRAWAL; EDEMA; FEMALE; HAND DISEASE; HUMAN; IMMUNOBLOTTING; LARYNX DISORDER; LIP DISEASE; PILL; PRIORITY JOURNAL; PROTEIN DEGRADATION; REMISSION; SKIN MANIFESTATION;

ADULT; ANGIONEUROTIC EDEMA; COMPLEMENT C1 INACTIVATOR PROTEINS; CONTRACEPTIVES, ORAL, HORMONAL; FEMALE; HUMANS; IMMUNOBLOTTING; RETROSPECTIVE STUDIES; SERPINS;

EID: 12244255797     PISSN: 10188665     EISSN: None     Source Type: Journal    
DOI: 10.1159/000068456     Document Type: Article

References (12)

1. Bork K, Barnstedt SE, Koch P, Traupe H: Hereditary angioedema with normal C1 inhibitor activity in women. Lancet 2000;356:213-217.
2. McGlinchey PG, McCluskey DR: Hereditary angioedema precipitated by estrogens replacement therapy in a menopausal woman. Am J Med Sci 2000;320:212-213.
3. Warin RP, Cunliffe WJ, Greaves MW, Wallington TB: Recurrent angioedema: Familial and estrogens induced. Br J Dermatol 1986; 115:731-734.
4. 1 inhibitor activity. Clin Chim Acta 1988;174:121-130.
5. Binkley KE, Davis A: Clinical, biochemical, and genetic characterization of a novel estrogen dependent inherited form of angioedema. J Allergy Clin Immunol 2000;106:546-550.
6. Gordon EM, Ratnoff OD, Saito H, Donaldson VH, Pensky J, Joes PK: Rapid fibrinolysis, augmented Hageman factor (factor XII) titers, and decreased C1 esterase inhibitor titers in women taking oral contraceptives. J Lab Clin Med 1980;96:762-769.
7. Pichler WJ, Lehner R, Spath PJ: Recurrent angioedema associated with hypogonadism or anti-androgen therapy. Ann Allergy 1989;63:301-305.
8. Fields T, Ghebrehiwet B, Kaplan AP: Kinin formation in HANE plasma: Evidence against kinin derivation from C2 and in support of spontaneous formation of bradykinin. J Allergy Clin Immunol 1983;72:54-60.
9. Nussberger J, Cugno M, Amstutz C, Cicardi M, Pellacani A, Agostoni A: Plasma bradykinin in angio-oedema. Lancet 1998;351:1693-1697.
10. Czendlik C, Lämmle B, Duckert F: Cold promoted activation and factor XII, prekallikrein and C1-inhibitor. Thromb Haemost 1985;53:242-244.
11. Van Royen EA, Lohman S, Voss M, Pondman KW: C1 inactivator and cold promoted activation of factor VII. J Lab Clin Med 1978;92: 152-163.
12. Nilsson T, Back O: On the role of C1 esterase inhibitor in cold urticaria. Acta Derm Venereol 1984;64:197-202.